Evidence map›Paper›PMID 41209337›Full record

ArticleMethodsX2025

Patient reported outcome measures relevant to asthma remission: scoping review protocol.

Allison Michaud, John Politis, Lachlan Faktor, Philip G Bardin, Amy Hy Chan, Paul Leong

Abstract read
In one paragraph

Article in MethodsX, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Patient-reported outcome measures applied in chronic diseases relevant to asthma remission: a scoping review.European respiratory review : an official journal of the European Respiratory Society · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Allison MichaudMonash Lung Sleep Allergy and Immunology and School of Clinical Sciences, Monash Health and Hudson Institute of Medical Research, Monash University, Melbourne, VIC, Australia.
John PolitisMonash Lung Sleep Allergy and Immunology and School of Clinical Sciences, Monash Health and Hudson Institute of Medical Research, Monash University, Melbourne, VIC, Australia.
Lachlan FaktorMonash Lung Sleep Allergy and Immunology and School of Clinical Sciences, Monash Health and Hudson Institute of Medical Research, Monash University, Melbourne, VIC, Australia.
Philip G BardinMonash Lung Sleep Allergy and Immunology and School of Clinical Sciences, Monash Health and Hudson Institute of Medical Research, Monash University, Melbourne, VIC, Australia.
Amy Hy ChanSchool of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
Paul LeongMonash Lung Sleep Allergy and Immunology and School of Clinical Sciences, Monash Health and Hudson Institute of Medical Research, Monash University, Melbourne, VIC, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Asthma affects over 260 million people globally. Recent advances in asthma care have highlighted remission as a key treatment goal. While remission requires agreement between patients and healthcare providers, there is no standard way to assess the patient experience of remission. This scoping review aims to identify validated Patient Reported Outcome Measures (PROMs) that capture patient experiences of disease remission and may be applicable to asthma. Determining items and domains that are most important to patients will inform the development of a conceptual framework for a PROM for asthma remission. Methods and Analysis: This review will identify PROMs that quantify remission in long-term diseases. It will follow the Joanna Briggs Institute Manual and the PRISMA-ScR guidelines. Two independent reviewers will screen titles and abstracts following a training and calibration phase. Data extraction will also be performed independently by two authors, with disagreements resolved through discussion or a third reviewer. Ethics and Dissemination: No ethics approval is required as no human participants are involved. Findings will be shared at academic conferences and published in peer-reviewed journals.

Indexed as

Asthma patient experienceChronic illness measurement toolsDisease remission assessment

Identifiers

PMID41209337
PMCPMC12590250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.